Ally Financial’s Bristol-Myers Squibb BMY Stock Holding History

Ally Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-41,000	Closed	-$2.32M	–	115
2024 Q4	$2.32M	Sell	41,000 -44,000	-52%	-$2.46M	0.28%	68
2024 Q3	$4.4M	Hold	85,000	–	–	0.53%	43
2024 Q2	$3.53M	Hold	85,000	–	–	0.44%	54
2024 Q1	$4.61M	Hold	85,000	–	–	0.62%	44
2023 Q4	$4.36M	Buy	85,000 +19,000	+29%	+$997K	0.57%	45
2023 Q3	$3.83M	Buy	+66,000	New	+$4.04M	0.56%	50
2022 Q2	–	Sell	-60,000	Closed	-$4.38M	–	117
2022 Q1	$4.38M	Hold	60,000	–	–	0.5%	50
2021 Q4	$3.74M	Hold	60,000	–	–	0.34%	61
2021 Q3	$3.55M	Hold	60,000	–	–	0.35%	63
2021 Q2	$4.01M	Hold	60,000	–	–	0.4%	69
2021 Q1	$3.79M	Hold	60,000	–	–	0.36%	67
2020 Q4	$3.72M	Hold	60,000	–	–	0.35%	69
2020 Q3	$3.62M	Buy	60,000 +46,000	+329%	+$2.77M	0.58%	57
2020 Q2	$823K	Hold	14,000	–	–	0.14%	104
2020 Q1	$780K	Hold	14,000	–	–	0.08%	115
2019 Q4	$899K	Sell	14,000 -6,000	-30%	-$344K	0.15%	108
2019 Q3	$1.01M	Hold	20,000	–	–	0.18%	94
2019 Q2	$907K	Buy	+20,000	New	+$932K	0.16%	93
2018 Q3	–	Sell	-20,000	Closed	-$1.11M	–	111
2018 Q2	$1.11M	Buy	+20,000	New	+$1.08M	0.22%	95
2017 Q3	–	Sell	-55,000	Closed	-$3.06M	–	114
2017 Q2	$3.06M	Hold	55,000	–	–	0.61%	60
2017 Q1	$2.99M	Buy	55,000 +20,000	+57%	+$1.1M	0.67%	48
2016 Q4	$2.04M	Buy	35,000 +5,000	+17%	+$273K	0.34%	75
2016 Q3	$1.62M	Buy	+30,000	New	+$1.93M	0.28%	80
2014 Q4	–	Sell	-100,000	Closed	-$5.12M	–	135
2014 Q3	$5.12M	Hold	100,000	–	–	0.7%	52
2014 Q2	$4.85M	Buy	+100,000	New	+$4.93M	0.57%	71

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ally Financial's BMY Position: Q1 2025 in Review

Ally Financial sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 41,000 shares — an estimated $2.32M sold.

Ally Financial first reported a position in BMY in Q2 2014 and held it in 25 quarters. The position peaked at $5.12M in Q3 2014. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Ally Financial reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Ally Financial sold 41,000 Bristol-Myers Squibb shares in Q1 2025, an estimated $2.32M.
Ally Financial first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 25 quarters.
Ally Financial's Bristol-Myers Squibb position peaked at $5.12M in Q3 2014.
2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Ally Financial's 13F filing for Q1 2025, filed 14 May 2025.